We are live on ! Find out more
CELG

Celgene Corp
CELG

Delisted

CELG was delisted on the 20th of November, 2019.

1,245 hedge funds and large institutions have $56.9B invested in Celgene Corp in 2019 Q3 according to their latest regulatory filings, with 73 funds opening new positions, 350 increasing their positions, 572 reducing their positions, and 106 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding in top 10

Funds holding in top 10: 109127 (+18)

12% more capital invested

Capital invested by funds: $51.1B → $56.9B (+$5.88B)

3% less funds holding

Funds holding: 1,2871,245 (-42)

31% less first-time investments, than exits

New positions opened: 73 | Existing positions closed: 106

39% less repeat investments, than reductions

Existing positions increased: 350 | Existing positions reduced: 572

59% less call options, than puts

Call options by funds: $796M | Put options by funds: $1.95B

Holders
1,245
Holders Change
-42
Holders Change %
-3.26%
% of All Funds
27.3%
Holding in Top 10
127
Holding in Top 10 Change
+18
Holding in Top 10 Change %
+16.51%
% of All Funds
2.79%
New
73
Increased
350
Reduced
572
Closed
106
Calls
$796M
Puts
$1.95B
Net Calls
-$1.15B
Net Calls Change
-$98.3M
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
101
Redwood Capital Management
New York
$84.9M
National Pension Service
102
National Pension Service
South Korea
$84.3M +$3.82M +40,253 +5%
GF
103
Gabelli Funds
New York
$82.2M +$3.01M +31,630 +4%
US Bancorp
104
US Bancorp
Minnesota
$80.2M -$2.14M -22,544 -3%
EVM
105
Eaton Vance Management
Massachusetts
$79.7M -$2.82M -29,656 -4%
Stifel Financial
106
Stifel Financial
Missouri
$79.5M -$16M -168,896 -17%
Two Sigma Investments
107
Two Sigma Investments
New York
$73.7M -$75.5M -794,210 -52%
Swedbank
108
Swedbank
Sweden
$73.2M -$4.14M -43,589 -6%
DLA
109
Douglas Lane & Associates
New York
$72.6M -$773K -8,139 -1%
Grantham, Mayo, Van Otterloo & Co (GMO)
110
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$72.5M -$2.63M -27,700 -4%
O
111
Ossiam
France
$71.9M +$37.4M +393,907 +119%
Canada Life
112
Canada Life
Manitoba, Canada
$71.4M +$6.8M +71,535 +11%
TS
113
Twin Securities
New York
$70.1M +$36.4M +383,313 +119%
SB
114
Suntrust Banks
Georgia
$70.1M -$1.28M -13,464 -2%
ProShare Advisors
115
ProShare Advisors
Maryland
$70M +$3.7M +38,887 +6%
BC
116
Birchview Capital
Vermont
$69.5M +$188K +1,981 +0.3%
RA
117
Ramius Advisors
New York
$68.9M +$65.9M +693,905 New
IA
118
IndexIQ Advisors
New York
$68.4M +$4.55M +47,833 +7%
Manulife (Manufacturers Life Insurance)
119
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$67.7M +$2.98M +31,398 +5%
VI
120
Versor Investments
New York
$67.2M +$16.8M +176,585 +35%
HSBC Holdings
121
HSBC Holdings
United Kingdom
$66.2M -$2.53M -26,629 -4%
Prudential Financial
122
Prudential Financial
New Jersey
$66.1M -$206K -2,163 -0.3%
Mitsubishi UFJ Trust & Banking
123
Mitsubishi UFJ Trust & Banking
Japan
$65.9M +$9.88M +103,953 +19%
DekaBank Deutsche Girozentrale
124
DekaBank Deutsche Girozentrale
Germany
$65.4M -$36.8M -387,457 -37%
Two Sigma Advisers
125
Two Sigma Advisers
New York
$64M -$96.8M -1,018,400 -61%

CELG Hedge Fund Activity: Q3 2019 in Review

1,245 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q3 2019, worth a combined $56.9B — up 12% from $51.1B a quarter earlier.

Sellers outnumbered buyers: 106 funds closed out of CELG and 73 opened new positions — a net loss of 33 holders — while 572 trimmed existing stakes and 350 added.

The largest buyer was HBK Investments, opening a new position worth an estimated $1.5B. The largest seller was Fidelity Investments, cutting an estimated $377M.

  • 1,245 institutional investors held Celgene Corp (CELG) as of Q3 2019, down from 1,287 in Q2 2019.
  • Funds reported $56.9B of Celgene Corp stock for Q3 2019, up 12% quarter-over-quarter.
  • 73 funds opened new Celgene Corp positions in Q3 2019 and 106 closed out, a net change of -33 holders.
  • The largest Celgene Corp buyer in Q3 2019 was HBK Investments, an estimated $1.5B added.
  • The largest Celgene Corp seller in Q3 2019 was Fidelity Investments, an estimated $377M sold.

Based on aggregated 13F filings for Q3 2019.